Abstract
Gliocidin can target brain tumours by disrupting the production of nucleotides needed for cell growth. The molecule’s unusual ability to cross the blood–brain barrier suggests a promising way to develop therapies.
Original language | English (US) |
---|---|
Pages (from-to) | 307-308 |
Number of pages | 2 |
Journal | Nature |
Volume | 636 |
Issue number | 8042 |
DOIs |
|
State | Published - Dec 12 2024 |
Keywords
- Cancer
- Medical research
ASJC Scopus subject areas
- General